The Latest Breaking News from Johnson & Johnson (

MSF reiterated its call for Johnson & Johnson to publicly announce that it will not enforce any ‘secondary’ patents for bedaquiline in any country with a high burden of TB, as J&J’s 20-year primary patent on bedaquiline expired on July 18.

AT&T's plump dividend used to be like money in the bank. But now investors seeking income and safety might look elsewhere.

Johnson & Johnson allows generic bedaquiline in 44 countries – but concerns remain about ‘stopgap’ solution

Disease kills millions each year even though it’s curable

The debate over how to interpret acetaminophen science has profound implications for individuals and the public

After a joint FBI task force was unable to pin the 1982 Tylenol murders on prime suspect James Lewis, special agent Roy Lane was coaxed out of retirement to carry out a daring undercover mission. He tells Bevan Hurley Lewis’ death this week ‘puts the pursuit of justice to an…

James Lewis was found unresponsive at his residence in Cambridge, Mass. His death was determined to be not suspicious, police said.

Think you missed your chance to profit on the S&P 500's most valuable stocks? Good news: analysts say there's still upside for most of them.

Fortune 500 companies, including Salesforce and Microsoft, reacted to the Supreme Court's decision to reject affirmative action at U.S. colleges and universities.

The long read: It has been said that condoms share marketing characteristics with napalm and funerals. But it is Ben Wilson’s mission to make us believe they are key to human happiness

The Chart of the Day belongs to the healthcare company Johnson & Johnson (JNJ) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...